TSU-68 |
5-[1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid |
(CAS 252916-29-3) |
 |
Description: |
TSU-68 has greatest potency against PDGFR autophosphorylation with Ki of 8 nM, but also strongly inhibits Flk-1 and FGFR1 trans-phosphorylation, little activity against IGF-1R, Met, Src, Lck, Zap70, Abl and CDK2; does not inhibit EGFR.
SU 6668 is an inhibitor of the receptor tyrosine kinases PDGFRβ, VEGFR2, and FGFR1 (IC50 = 0.06, 2.4, and 3.0 μM, respectively) but not EGFR (IC50 >100 μM).Through these actions, SU 6668 suppresses tumor growth, blocks angiogenesis in tumors, and induces apoptosis of tumor vasculature and regression of established tumors.It also inhibits metastasis in a mouse orthotopic model of melanoma.SU 6668 also inhibits Aurora kinases B and C (IC50 = 35 and 210 nM, respectively) and may target other kinases.
|
Product No. |
KT00921 |
Product Name |
TSU-68 |
Synonyms |
TSU-68;NSC 702827;Orantinib |
Formal Name |
5-[1,2-Dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid |
CAS Number |
252916-29-3 |
Molecular Formula |
C18H18N2O3 |
Formula Weight |
310.35 |
Formulation |
A crystalline solid |
Purity |
98%min |
Stability |
2 years |
Storage |
-20°C |
Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
Price & Availability |
In Stock. Price Negotiated. |
|
Related Products: |
ABT-869
AG-126
AG-1296
AG-370
AG-825
AG-879
AT-9283
BAY-43-9006
BIBF 1120
Cediranib
Dovitinib
JNJ-10198409
KRN 633
PD 166326
PD 173074
PKC 412
|
|